EyeSouth Partners, a portfolio company of Shore Capital Partners, has invested in Retina Associates of Middle Georgia, a provider of medical and surgical eye care services. No financial terms were disclosed.
ATLANTA, August 6, 2020 – EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with Retina Associates of Middle Georgia (“RAMG”). The affiliation represents EyeSouth’s eighth in the state of Georgia and eighteenth affiliation overall. EyeSouth is an eye care-focused management services organization backed by Shore Capital Partners, committed to partnering with leading physicians to build a premier network of eye care services in the South.
EyeSouth’s affiliate network consists of 18 practices with approximately 126 doctors providing medical and surgical eye care services at approximately 73 locations including 11 surgery centers throughout Georgia, Texas, Louisiana, North Carolina, Florida, Tennessee, and Alabama.
Retina Associates of Middle Georgia is led by Drs. Norman Nelson, Steven Allee and Arpan Bachhawat. RAMG employs approximately 30 support staff across two primary clinical locations in the Middle Georgia area. For nearly 30 years, Retina Associates of Middle Georgia and its board-certified ophthalmologists have offered first-class expertise in the treatment of diseases of the retina, macula, and vitreous to patients throughout Middle Georgia, including a strong commitment to providing care in underserved areas.
“Our primary goal at Retina Associates of Middle Georgia has always been to deliver exceptional medical and surgical retinal care combined with an outstanding patient experience,” said Dr. Norman Nelson, who founded RAMG in 1992. “To further build upon this mission in the rapidly changing healthcare environment, we have decided to affiliate with EyeSouth as our partners to help us strengthen and expand our operational and administrative capabilities.”
“Despite the ongoing challenges that our country faces with COVID-19, EyeSouth is committed to affiliating with the highest quality ophthalmology practices. Drs. Nelson, Allee and Bachhawat maintain a longstanding reputation for delivering best-in-class patient care throughout Middle Georgia. We are looking forward to taking this partnership to the next level and providing our expertise and best practices to continue Retina Associates of Middle Georgia’s history of practice growth and commitment to serving the local community,” said Eugene Gabianelli, M.D., Chief Medical Officer of EyeSouth Partners.
To learn more about a partnership with EyeSouth Partners, visit www.eyesouthpartners.com or contact Charlie Shreve, VP of Business Development & Strategy, email@example.com.
About EyeSouth Partners
Headquartered in Atlanta, GA, EyeSouth Partners (“EyeSouth”) is an eye care management services organization committed to partnering with leading physicians to build a premier network of eye care services in the Southern U.S. EyeSouth’s partner practices’ clinical mission is to provide high quality medical and surgical specialty eye care. EyeSouth supports its affiliated practices and physician partners with strategic guidance, administrative resources, operating expertise, and capital with an absolute focus on clinical quality and a patient-first culture. EyeSouth’s affiliate network consists of approximately 126 doctors providing medical and surgical eye care services at approximately 73 locations throughout Georgia, Texas, Louisiana, North Carolina, Florida, Tennessee, and Alabama. EyeSouth is backed by Shore Capital Partners, a Chicago-based private equity firm focused on microcap healthcare and food & beverage investments. For more information about EyeSouth Partners, please visit: www.eyesouthpartners.com.
About Shore Capital Partners
Shore Capital Partners is a Chicago-based private equity firm focused on microcap healthcare and food & beverage investments. Shore supports management partners with capital, business development expertise, and industry knowledge to accelerate growth, fund acquisitions, and generate value to shareholders. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant growth potential, including organic and growth through industry consolidation. Shore has over $1 billion of equity capital under management through various investment vehicles. More information about Shore Capital Partners can be found at www.shorecp.com.